Search research articles
Contact Us
Filters
Showing results (11-20 of 106) with videos related to
Page
of 11
Sort By:
Blood Advances
|
April 12, 2023
Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia
Amber Afzal, Mark A Fiala, Meagan A Jacoby, et al.
Experimental Hematology
|
January 1, 2015
Reduced levels of Hspa9 attenuate Stat5 activation in mouse B cells
Kilannin Krysiak, Justin F Tibbitts, Jin Shao, et al.
Plos One
|
February 9, 2017
Knockdown of HSPA9 induces TP53-dependent apoptosis in human hematopoietic progenitor cells
Tuoen Liu, Kilannin Krysiak, Cara Lunn Shirai, et al.
Breast Cancer Research and Treatment
|
March 27, 2009
Therapy related acute myeloid leukemia in breast cancer survivors, a population-based study
Mike G Martin, John S Welch, Jingqin Luo, et al.
Blood
|
September 30, 2006
Expression of a bcr-1 isoform of RARalpha-PML does not affect the penetrance of acute promyelocytic leukemia or the acquisition of an interstitial deletion on mouse chromosome 2
Matthew J Walter, Rhonda E Ries, Jon R Armstrong, et al.
JAAD Case Reports
|
December 13, 2023
Progressive, edematous plaques, mild pancytopenia, and inflammation
Leigh A Compton, Heather A Jones, Connor A Vinyard, et al.
Personalized Medicine
|
February 18, 2010
Next-generation sequencing of cancer genomes: back to the future
Matthew J Walter, Timothy A Graubert, John F Dipersio, et al.
Blood
|
December 3, 2010
Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice
Tim H-P Chen, Amal Kambal, Kilannin Krysiak, et al.
JCI Insight
|
February 28, 2023
Increased clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation
Laneshia K Tague, Karolyn A Oetjen, Anirudh Mahadev, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 22, 2002
Adaptive immunity cooperates with liposomal all-trans-retinoic acid (ATRA) to facilitate long-term molecular remissions in mice with acute promyelocytic leukemia
Peter Westervelt, Jessica L Pollock, Kristie M Oldfather, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 106) with videos related to
Sort By:
Page
of 11
Blood Advances
|
April 12, 2023
Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia
Amber Afzal, Mark A Fiala, Meagan A Jacoby, et al.
Experimental Hematology
|
January 1, 2015
Reduced levels of Hspa9 attenuate Stat5 activation in mouse B cells
Kilannin Krysiak, Justin F Tibbitts, Jin Shao, et al.
Plos One
|
February 9, 2017
Knockdown of HSPA9 induces TP53-dependent apoptosis in human hematopoietic progenitor cells
Tuoen Liu, Kilannin Krysiak, Cara Lunn Shirai, et al.
Breast Cancer Research and Treatment
|
March 27, 2009
Therapy related acute myeloid leukemia in breast cancer survivors, a population-based study
Mike G Martin, John S Welch, Jingqin Luo, et al.
Blood
|
September 30, 2006
Expression of a bcr-1 isoform of RARalpha-PML does not affect the penetrance of acute promyelocytic leukemia or the acquisition of an interstitial deletion on mouse chromosome 2
Matthew J Walter, Rhonda E Ries, Jon R Armstrong, et al.
JAAD Case Reports
|
December 13, 2023
Progressive, edematous plaques, mild pancytopenia, and inflammation
Leigh A Compton, Heather A Jones, Connor A Vinyard, et al.
Personalized Medicine
|
February 18, 2010
Next-generation sequencing of cancer genomes: back to the future
Matthew J Walter, Timothy A Graubert, John F Dipersio, et al.
Blood
|
December 3, 2010
Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice
Tim H-P Chen, Amal Kambal, Kilannin Krysiak, et al.
JCI Insight
|
February 28, 2023
Increased clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation
Laneshia K Tague, Karolyn A Oetjen, Anirudh Mahadev, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 22, 2002
Adaptive immunity cooperates with liposomal all-trans-retinoic acid (ATRA) to facilitate long-term molecular remissions in mice with acute promyelocytic leukemia
Peter Westervelt, Jessica L Pollock, Kristie M Oldfather, et al.
Page
of 11